Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 427.00
Bid: 423.50
Ask: 429.50
Change: 0.00 (0.00%)
Spread: 6.00 (1.417%)
Open: 427.00
High: 427.00
Low: 427.00
Prev. Close: 427.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

7 Apr 2020 07:00

RNS Number : 9761I
Treatt PLC
07 April 2020
 

 

 

7 April 2020

 

TREATT PLC

("Treatt" or "the Group")

 

Trading update for the half year ended 31 March 2020

 

Treatt, the manufacturer and supplier of innovative ingredient solutions for the beverage, flavour, fragrance and consumer product industries today publishes a trading update for the half year ended 31 March 2020 (the "Period").

 

Treatt plays a critical role in the food, beverage and cleaning supply chains and order intake in recent weeks has been strong as a number of our customers respond to increased demand for beverages consumed at home and cleaning products (such as liquid hand soaps and floor cleaning products) which are of particular importance at this time.

 

As such, the Board can confirm that, to date, there has not been any adverse effect on the trading performance of the Group due to COVID-19 and the Group is currently trading in line with the Board's expectations.

 

The business has taken, and will continue to take, timely action to protect the health and safety of all its employees across the Group as well as doing all it can to support the communities in which it operates. We received early indications of the likely steps that would follow from our colleagues in Shanghai, where our office remained open, albeit operating for one month on a staff rota, and whom we are pleased to say have now all returned to work. In both the UK and US all non-essential staff are working from home and manufacturing continues, working within government guidelines and with appropriate health protection and wellbeing measures in place.

 

As previously reported, we expected the sharp fall in citrus raw material prices in the last financial year to continue to impact upon revenue in the first half of the current financial year. Consequently, whilst in-line with expectations, revenue for the Period is expected to be approximately 5.1% lower as compared with the same period in the prior year (5.6% lower in constant currency).

 

Whilst citrus remains a significant part of the Group's business, there was good growth in reported revenue from fruit and vegetables (up 9.4%), tea (up 47.5%) and health and wellness (incl. sugar reduction) (up 19.9%). The vast majority of Treatt's portfolio is targeted at the growing demand from consumers for more natural and clean-label products which is helping to drive our financial performance as well as our encouraging opportunity pipeline. Our customers continue to look to product innovation to differentiate their products, launch new products and categories and refresh existing products. Treatt continues to benefit from the valuable role our services play in helping meet these demands with the Group's new product development programme progressing well with market entry points currently being explored.

 

Building work on our new facility in the UK has inevitably slowed as a consequence of the COVID-19 pandemic. We now expect that our UK relocation may not take place until 2021 but at this stage it is not possible to confirm a new definitive timescale. The delay to our UK relocation will not affect our ability to meet customer orders in the short to medium term but such a delay does enable the Group to preserve cash during this period of uncertainty. At the end of the Period the Group had net cash of £6.5m and total bank facilities of £25.0m, of which £24.9m remains undrawn.

 

As previously reported, the expansion of our US manufacturing facility was completed last year and is now fully operational. Our capacity for products in our fast-growing fruit and vegetables, health and wellness and tea product categories has now doubled and is coming on stream in time for the new crop season as growth in these categories continues from both new and existing customers.

 

The Group has a hedging strategy in place to try to minimise the impact of exchange rate movements over the course of a financial year though there can be material effects over shorter periods of time. During the Period there was a strengthening in the USD/GBP exchange rate and, as a result, the Board anticipates a net positive FX impact on the results for the Period of approximately £0.6m.

 

Outlook

The focus we have made over recent years on the culture in the business means that we have an incredibly strong and committed team of employees who we know will shine in these exceptional times, whilst protecting the health and safety of each other and the wider communities in which we operate.

 

The business is both trading well and is financially robust; we are encouraged by our order book and current demand as we move into our peak seasonal period. Also, and as expected, citrus raw material prices are firming once more, which should result in a stronger performance from our citrus category in the second half of the financial year. Whilst it is difficult to determine the likely impact of COVID-19 on the demand for the Group's products in the coming months, our early experience has shown demand to be robust and at this time, trading remains in line with the Board's expectations.

 

It is currently expected that Treatt's half year results for the six months ended 31 March 2020 will be announced on 12 May 2020.

 

Enquiries:

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Broker

Investec Investment Banking

Patrick Robb +44 (0)20 7597 5970

David Anderson

Alex Wright

 

Public relations

DRD Partnership

Lawrence Dore +44 (0)20 3951 0349

 

About the Group

Treatt is a global, independent supplier of innovative ingredient solutions for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America, Africa and Asia and has manufacturing facilities in the UK, USA and Kenya. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFITSVIRIII
Date   Source Headline
19th Mar 20243:40 pmRNSNotification of Transactions of Directors
4th Mar 20247:00 amRNSAppointment of Chief Executive Officer
13th Feb 20249:35 amRNSHolding(s) in Company
31st Jan 20242:41 pmRNSNotification of Transaction of PDMR
25th Jan 20243:49 pmRNSResult of AGM
25th Jan 20247:00 amRNSAGM Trading Update
23rd Jan 20241:57 pmRNSTotal Voting Rights
21st Dec 20232:07 pmRNSNotification of Transaction of Director
15th Dec 20236:09 pmRNSNotification of Transactions - Replacement
15th Dec 20234:42 pmRNSNotification of Transactions of Directors
13th Dec 20237:00 amRNSInterim Chief Financial Officer Appointment
12th Dec 20234:24 pmRNSAnnual Report and Notice of Annual General Meeting
1st Dec 20237:01 amRNSBlock Listing Six Monthly Return
1st Dec 20237:00 amRNSBlock Listing Six Monthly Return
28th Nov 20234:15 pmRNS2023 Final Dividend
28th Nov 20237:00 amRNSFull Year Results
20th Oct 20237:00 amRNSCEO Succession
10th Oct 20237:00 amRNSTrading Update
18th Sep 20234:11 pmRNSHolding(s) in Company
15th Aug 20234:14 pmRNSNotification of Transactions of Directors
28th Jul 202310:43 amRNSTotal Voting Rights
13th Jul 202312:15 pmRNSReplacement - Director/PDMR Shareholding
13th Jul 202311:09 amRNSNotification of Transaction of Director
21st Jun 20234:05 pmRNSNotification of Transactions of Director
12th Jun 20234:13 pmRNSDirector Declaration
7th Jun 20232:28 pmRNSBlock Listing Application
1st Jun 20237:00 amRNSBlock listing Six Monthly Return
19th May 20235:10 pmRNSHolding(s) in Company
19th May 20234:28 pmRNSHolding(s) in Company
9th May 20237:00 amRNSHalf Year Results
12th Apr 20237:00 amRNSHalf Year Trading Update and Notice of Results
20th Mar 20233:28 pmRNSNotification of Transactions of Directors
7th Mar 20233:25 pmRNSDirector/PDMR Shareholding
22nd Feb 20233:06 pmRNSHolding(s) in Company
21st Feb 202312:51 pmRNSNotification of Transactions of Director
21st Feb 202312:49 pmRNSNotification of Transactions of Director
20th Feb 202311:01 amRNSNotification of Transaction of a Director
30th Jan 20231:49 pmRNSHolding(s) in Company
27th Jan 20233:10 pmRNSResult of AGM
27th Jan 20237:00 amRNSAGM Trading Update
10th Jan 20235:05 pmRNSVoting Rights and Capital
28th Dec 20227:00 amRNSNotification of Transaction of Director
28th Dec 20227:00 amRNSAnnual Report and Notice of Annual General Meeting
20th Dec 202212:20 pmRNSBoard Appointment and Board Committee Changes
16th Dec 20221:25 pmRNSNotification of Transactions of Directors
1st Dec 20223:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20223:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
29th Nov 20224:36 pmRNSPrice Monitoring Extension
29th Nov 20227:10 amRNSFull Year Results
10th Nov 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.